stockrowHalozyme Therapeutics, Inc.
HALO Healthcare Biotechnology
Halozyme Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 37.6% from fiscal 2024.
- Revenue
- +39.2%
- EPS
- +45.6%
- Free cash flow
- −58.6%
- Total debt
- +115.1%
Quarter to September 2026, against a year earlier
Follow HALO
Alert me
Halozyme Therapeutics, Inc. (HALO) Gross margin
Halozyme Therapeutics, Inc.'s gross margin over the twelve months to 30 September 2026 was 82.3%, down 1.4 percentage points from fiscal 2025 (83.6%). Over the past ten years it has ranged from 76.8% (fiscal 2019) to 93.3% (fiscal 2018); the current reading is higher than 64% of that period. That is above the Biotechnology industry median of 65.2% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 83.6% | (0.68) |
| FY2024 | 84.3% | 7.50 |
| FY2023 | 76.8% | (2.10) |
| FY2022 | 78.9% | (2.74) |
| FY2021 | 81.6% | (2.15) |
| FY2020 | 83.8% | 7.03 |
| FY2019 | 76.8% | (16.57) |
| FY2018 | 93.3% | 3.17 |
| FY2017 | 90.2% | 12.80 |
| FY2016 | 77.4% | (0.99) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 83.3% | (0.27) |
| Jun 2026 | 83.5% | 4.57 |
| Mar 2026 | 79.0% | (3.59) |
| Dec 2025 | 82.6% | (1.85) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| SMMT Summit Therapeutics PLC compare | 100.0% |
| KYMR Kymera Therapeutics, Inc. compare | 100.0% |
| EXEL Exelixis, Inc. compare | 96.3% |
| BBIO BridgeBio Pharma, Inc. compare | 94.3% |
| ASND Ascendis Pharma A/S compare | 91.3% |
| JAZZ Jazz Pharmaceuticals PLC compare | 89.1% |
| HALO Halozyme Therapeutics, Inc. | 82.3% |
| BMRN BioMarin Pharmaceutical Inc. compare | 76.0% |
| TECH Bio-Techne Corp compare | 65.8% |
| Biotechnology industry median | 65.2% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on HALO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement